Top compounds associated with response to MT-CYB


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.06
mRNA SCH-529074 CTRPv2 pan-cancer AAC -0.078 0.06
mRNA tivozanib CTRPv2 pan-cancer AAC -0.075 0.06
mRNA STF-31 CTRPv2 pan-cancer AAC -0.072 0.06
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.06
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.06
mRNA Bosutinib CTRPv2 pan-cancer AAC 0.07 0.06
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.06
mRNA fluvastatin CTRPv2 pan-cancer AAC -0.074 0.07
Download CSV